Sign in
Groups
Researchers
Results
GUILLERMO
LÓPEZ VIVANCO
Researcher to 2022
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, España
You are in
Collaborations
Hospital Universitario Nuestra Señora de Candelaria
Publications in collaboration with researchers from Hospital Universitario Nuestra Señora de Candelaria (2)
2022
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
2012
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de